Furthermore, we found that PCBP1 overexpression contributes to up-regulation of mesenchymal marker vimentin while down-regulation of epithelial marker E-cadherin both in-vitro and in-vivo, which reversed C12orf48-mediating EMT in gastric cancer. This evidence concerns the gene VIM and gastric cancer.